Four advances that are improving patients’ lives and preparing us for future health challenges.
All tagged cancer
Four advances that are improving patients’ lives and preparing us for future health challenges.
Three ways scientists at U of U Health aim to understand biology down to its very molecules.
Combining bevacizumab with erlotinib shrinks tumors in patients with aggressive, HLRCC-associated kidney cancers.
Researchers have learned how neurons in the brain can be damaged by the chemotherapy drug Ara-C.
A novel therapy helps eliminate recurring respiratory growths in patients — and the frequent surgeries they required.
Full story at National Cancer Institute
A personalized approach to cellular immunotherapy helps shrink solid tumors.
Cancer-killing natural killer cells could pave the way to off-the-shelf immunotherapy for solid tumors.
Adding a T-cell receptor to CAR T cells may reduce side effects of immunotherapies designed to target solid tumors.
U of U Health scientists open the door to clinical advances by examining the ways disease impacts the body, molecule by molecule.